Market Analysis Reports

Online Database of Chemicals from Around the World

Search | Submit | Advertise |

Home >> Chemical Listing >> AB928>> Market Analysis Reports

Metastatic Colorectal cancer - Pipeline Insight, 2022
... cancer. Etrumadenant: Arcus Biosciences Etrumadenant (AB928), the first dual A2a/A2b ... consistent with once-daily dosing. AB928 is currently being evaluated in several Phase ...

Adenosine A2B receptor antagonists - Pipeline Insight, 2022
... Drugs Etrumadenant: Arcus Biosciences Etrumadenant (AB928), the dual A2a/A2b adenosine ...